Work

Multidrug resistance‐1 (MDR‐1): a new target for T cell‐based immunotherapy

Year: 2004

Type: article

Source: The FASEB Journal

DOI: 10.1096/fj.04-2355fje

Authors: Andreas G. Niethammer, Harald Wodrich, Markus Loeffler, Holger N. Lode, Kathrin Emmerich, Amir Abdollahi, Robert Krempien, Juergen Debus, Peter E. Huber, Ralph A. Reisfeld

Institutions: Scripps Research Institute, Charité – Universitätsmedizin Berlin, Berliner Verkehrsbetriebe (Germany), Deutsche Börse (Germany)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Defense, Tobacco-Related Disease Research Program, National Institutes of Health, U.S. Public Health Service, National Cancer Institute

Awards: G163576652, G2443958122, NOVEL STRATEGIES FOR THE IMMUNOTHERAPY OF COLON CANCER, G3583258985, G7343039655, G7447597541

OpenAlex ID: W2142859591

FWCI: 0.805

Cites: 31

Cited by: 25

Related to: 10